{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:05:49Z","timestamp":1791608749905,"version":"4.3.4"},"reference-count":102,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Up to 60% of inflammatory bowel disease (IBD) patients experience abdominal pain in their lifetime regardless of disease activity. Pain negatively affects different areas of daily life and particularly impacts the quality of life of IBD patients. This review provides a comprehensive overview of the multifactorial etiology implicated in the chronic abdominal pain of IBD patients including peripheral sensitization by inflammation, coexistent irritable bowel syndrome, visceral hypersensitivity, alteration of the brain\u2013gut axis, and the multiple factors contributing to pain persistence. Despite the optimal management of intestinal inflammation, chronic abdominal pain can persist, and pharmacological and non-pharmacological approaches are necessary. Integrating psychological support in care models in IBD could decrease disease burden and health care costs. Consequently, a multidisciplinary approach similar to that used for other chronic pain conditions should be recommended.<\/jats:p>","DOI":"10.3390\/jcm11154269","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T12:53:45Z","timestamp":1658494425000},"page":"4269","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-6067","authenticated-orcid":false,"given":"Pauline","family":"Wils","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Claude Huriez Hospital, University of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Caron","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Lorraine, CHRU-Nancy, F-54000 Nancy, France"},{"name":"Department of Gastroenterology, University of Lorraine, Inserm, NGERE, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Lorraine, CHRU-Nancy, F-54000 Nancy, France"},{"name":"Department of Gastroenterology, University of Lorraine, Inserm, NGERE, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/apt.13001","article-title":"A Retrospective Analysis: The Development of Patient Reported Outcome Measures for the Assessment of Crohn\u2019s Disease Activity","volume":"41","author":"Khanna","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target Strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zeitz, J., Ak, M., M\u00fcller-Mottet, S., Scharl, S., Biedermann, L., Fournier, N., Frei, P., Pittet, V., Scharl, M., and Fried, M. (2016). Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156666"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00384-020-03727-3","article-title":"Abdominal Pain in Quiescent Inflammatory Bowel Disease","volume":"36","author":"Coates","year":"2021","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cgh.2018.08.001","article-title":"AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease: Expert Review","volume":"17","author":"Colombel","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1756283X12446158","article-title":"Pain Management in Patients with Inflammatory Bowel Disease: Insights for the Clinician","volume":"5","author":"Srinath","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1097\/j.pain.0000000000002304","article-title":"Chronic Pain in Patients with Inflammatory Bowel Disease","volume":"162","author":"Bakshi","year":"2021","journal-title":"Pain"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","article-title":"Brain-Gut Interactions in Inflammatory Bowel Disease","volume":"144","author":"Bonaz","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ecco-jcc\/jjw144","article-title":"What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance","volume":"11","author":"Hart","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/00365521.2012.743584","article-title":"Medication Use among Inflammatory Bowel Disease Patients: Excessive Consumption of Antidepressants and Analgesics","volume":"48","author":"Tanskanen","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohn\u2019s Disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/15360280802537225","article-title":"Opioid Side Effects and Their Treatment in Patients with Chronic Cancer and Noncancer Pain","volume":"22","author":"McNicol","year":"2008","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The Prevalence and Predictors of Opioid Use in Inflammatory Bowel Disease: A Population-Based Analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","article-title":"A Classification of Chronic Pain for ICD-11","volume":"156","author":"Treede","year":"2015","journal-title":"Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic Pain as a Symptom or a Disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The Short-Form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"ref_17","first-page":"351","article-title":"Brief Pain Inventory Score Identifying and Discriminating Neuropathic and Nociceptive Pain","volume":"128","author":"Erdemoglu","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-Analyses\u2014Part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/MCG.0b013e318266fff5","article-title":"Predictive Factors of Impaired Quality of Life in Korean Patients with Inactive Inflammatory Bowel Disease: Association with Functional Gastrointestinal Disorders and Mood Disorders","volume":"47","author":"Kim","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cgh.2016.05.012","article-title":"Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-Type Symptoms in Patients with Inflammatory Bowel Disease","volume":"15","author":"Gracie","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.3748\/wjg.v16.i25.3168","article-title":"Impact of Pain on Health-Related Quality of Life in Patients with Inflammatory Bowel Disease","volume":"16","author":"Schirbel","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/jcag\/gwy048","article-title":"The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life","volume":"2","author":"Jones","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.crohns.2007.06.005","article-title":"Impact of Inflammatory Bowel Disease on Quality of Life: Results of the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA) Patient Survey","volume":"1","author":"Ghosh","year":"2007","journal-title":"J. Crohns Colitis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41395-018-0021-z","article-title":"Longitudinal Impact of IBS-Type Symptoms on Disease Activity, Healthcare Utilization, Psychological Health, and Quality of Life in Inflammatory Bowel Disease","volume":"113","author":"Gracie","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.crohns.2014.03.005","article-title":"IBD and Health-Related Quality of Life\u2014Discovering the True Impact","volume":"8","author":"Vermeire","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2016.09.012","article-title":"Factors That Predict High Health Care Utilization and Costs for Patients with Inflammatory Bowel Diseases","volume":"15","author":"Limsrivilai","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ibd.20848","article-title":"Pain and Inflammatory Bowel Disease","volume":"15","author":"Bielefeldt","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s Disease Activity Index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of Irritable Bowel Syndrome-Type Symptoms in Patients with Inflammatory Bowel Disease in Remission: A Systematic Review and Meta-Analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2016.10.036","article-title":"Etiology and Treatment of Pain and Psychosocial Issues in Patients with Inflammatory Bowel Diseases","volume":"152","author":"Regueiro","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ejp.1140","article-title":"Assessment and Manifestation of Central Sensitisation across Different Chronic Pain Conditions","volume":"22","author":"Morlion","year":"2018","journal-title":"Eur. J. Pain"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lakhan, S.E., and Kirchgessner, A. (2010). Neuroinflammation in Inflammatory Bowel Disease. J. Neuroinflamm., 7.","DOI":"10.1186\/1742-2094-7-37"},{"key":"ref_33","first-page":"297","article-title":"Modulation of Microglia Can Attenuate Neuropathic Pain Symptoms and Enhance Morphine Effectiveness","volume":"60","author":"Mika","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0135-7","article-title":"Gastrointestinal Pain","volume":"6","author":"Drewes","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2982.2004.00596.x","article-title":"Inflammation-Induced Hyperexcitability of Nociceptive Gastrointestinal DRG Neurones: The Role of Voltage-Gated Ion Channels","volume":"17","author":"Beyak","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/j.pain.0000000000000479","article-title":"Differences in Regional Homogeneity between Patients with Crohn\u2019s Disease with and without Abdominal Pain Revealed by Resting-State Functional Magnetic Resonance Imaging","volume":"157","author":"Bao","year":"2016","journal-title":"Pain"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20873","article-title":"Depression and Anxiety in Inflammatory Bowel Disease: A Review of Comorbidity and Management","volume":"15","author":"Graff","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Thomann, A.K., Griebe, M., Thomann, P.A., Hirjak, D., Ebert, M.P., Szabo, K., Reindl, W., and Wolf, R.C. (2017). Intrinsic Neural Network Dysfunction in Quiescent Crohn\u2019s Disease. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-11792-y"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-Analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ajg.2012.260","article-title":"Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis","volume":"107","author":"Halpin","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2011.11.022","article-title":"Brain Responses to Visceral Stimuli Reflect Visceral Sensitivity Thresholds in Patients with Irritable Bowel Syndrome","volume":"142","author":"Larsson","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic Review with Meta-Analysis: The Prevalence of Anxiety and Depression in Patients with Irritable Bowel Syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., and Zhang, C. (2019). Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens, 8.","DOI":"10.3390\/pathogens8030126"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/ibd\/izy052","article-title":"No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease","volume":"24","author":"Shutkever","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Berezo, T., Pujo, J., Martin, P., Le Faouder, P., Galano, J.-M., Guy, A., Knauf, C., Tabet, J.C., Tronnet, S., and Barreau, F. (2017). Identification of an Analgesic Lipopeptide Produced by the Probiotic Escherichia Coli Strain Nissle 1917. Nat. Commun., 8.","DOI":"10.1038\/s41467-017-01403-9"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/apt.15133","article-title":"Systematic Review with Meta-Analysis: The Prevalence of Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease","volume":"49","author":"Shah","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpeds.2017.01.058","article-title":"Psychological Factors May Play an Important Role in Pediatric Crohn\u2019s Disease Symptoms and Disability","volume":"184","author":"Claar","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpsychores.2016.06.001","article-title":"Depression and Anxiety in Patients with Inflammatory Bowel Disease: A Systematic Review","volume":"87","author":"Neuendorf","year":"2016","journal-title":"J. Psychosom. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of Symptoms of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1053\/j.gastro.2018.01.027","article-title":"Bi-Directionality of Brain-Gut Interactions in Patients with Inflammatory Bowel Disease","volume":"154","author":"Gracie","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","article-title":"Inflammation Causes Mood Changes through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity","volume":"66","author":"Harrison","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and Inflammatory Bowel Disease: Findings from Two Nationally Representative Canadian Surveys","volume":"12","author":"Sulman","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ibd\/izaa115","article-title":"Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease","volume":"27","author":"Murphy","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/gut.2005.064261","article-title":"Psychological Stress in IBD: New Insights into Pathogenic and Therapeutic Implications","volume":"54","author":"Mawdsley","year":"2005","journal-title":"Gut"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/apt.14493","article-title":"Systematic Review: Psychosocial Factors Associated with Pain in Inflammatory Bowel Disease","volume":"47","author":"Sweeney","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MEG.0000000000001615","article-title":"Developing a Better Biopsychosocial Understanding of Pain in Inflammatory Bowel Disease: A Cross-Sectional Study","volume":"32","author":"Sweeney","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic Basis for Individual Variations in Pain Perception and the Development of a Chronic Pain Condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-Wide Association Study Implicates Immune Activation of Multiple Integrin Genes in Inflammatory Bowel Disease","volume":"49","author":"Moutsianas","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/gut.2009.194449","article-title":"Expression of the TRPV1 Receptor Differs in Quiescent Inflammatory Bowel Disease with or without Abdominal Pain","volume":"59","author":"Akbar","year":"2010","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gutjnl-2014-307997","article-title":"Exploring the Genetics of Irritable Bowel Syndrome: A GWA Study in the General Population and Replication in Multinational Case-Control Cohorts","volume":"64","author":"Ek","year":"2015","journal-title":"Gut"},{"key":"ref_62","unstructured":"The Swiss IBD Cohort Study Group, Ledergerber, M., Lang, B.M., Heinrich, H., Biedermann, L., Begr\u00e9, S., Zeitz, J., Krupka, N., Rickenbacher, A., and Turina, M. (2021). Abdominal Pain in Patients with Inflammatory Bowel Disease: Association with Single-Nucleotide Polymorphisms Prevalent in Irritable Bowel Syndrome and Clinical Management. BMC Gastroenterol., 21."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ecco-jcc\/jjx133","article-title":"Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies","volume":"12","author":"Vermeire","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/ecco-jcc\/jjab099","article-title":"Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates with Quality of Life Improvements in Patients with Moderate to Severe Ulcerative Colitis","volume":"15","author":"Ghosh","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00384-018-3218-0","article-title":"Focus on Current and Future Management Possibilities in Inflammatory Bowel Disease-Related Chronic Pain","volume":"34","author":"Fichna","year":"2019","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apt.14108","article-title":"Systematic Review: Interventions for Abdominal Pain Management in Inflammatory Bowel Disease","volume":"46","author":"Norton","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MCG.0b013e31821fbd82","article-title":"Understanding and Treating Abdominal Pain and Spasms in Organic Gastrointestinal Diseases: Inflammatory Bowel Disease and Biliary Diseases","volume":"45","author":"Makharia","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cgh.2017.05.014","article-title":"Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits","volume":"15","author":"Camilleri","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","article-title":"Increasing Prescription of Opiates and Mortality in Patients with Inflammatory Bowel Diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCG.0000000000000049","article-title":"Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease","volume":"48","author":"Iskandar","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0163-8343(96)00036-9","article-title":"The Relationship of Current Psychiatric Disorder to Functional Disability and Distress in Patients with Inflammatory Bowel Disease","volume":"18","author":"Walker","year":"1996","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gutjnl-2018-317182","article-title":"Depression Increases the Risk of Inflammatory Bowel Disease, Which May Be Mitigated by the Use of Antidepressants in the Treatment of Depression","volume":"68","author":"Frolkis","year":"2019","journal-title":"Gut"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","article-title":"Antibiotic Treatment of Small Bowel Bacterial Overgrowth in Patients with Crohn\u2019s Disease","volume":"18","author":"Castiglione","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic Review with Meta-Analysis: Rifaximin Is Effective and Safe for the Treatment of Small Intestine Bacterial Overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3748\/wjg.v18.i30.4012","article-title":"Clinical Trial: Lactobacillus Plantarum 299v (DSM 9843) Improves Symptoms of Irritable Bowel Syndrome","volume":"18","author":"Sawant","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2036.2011.04633.x","article-title":"Randomised Clinical Trial: Bifidobacterium Bifidum MIMBb75 Significantly Alleviates Irritable Bowel Syndrome and Improves Quality of Life\u2014A Double-Blind, Placebo-Controlled Study","volume":"33","author":"Guglielmetti","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal Nicotine for Active Ulcerative Colitis","volume":"330","author":"Pullan","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/030006059502300503","article-title":"Loperamide Oxide for the Treatment of Chronic Diarrhoea in Crohn\u2019s Disease","volume":"23","author":"Toussaint","year":"1995","journal-title":"J. Int. Med. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ibd\/izy319","article-title":"The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information","volume":"25","author":"Swaminath","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis Induces a Clinical Response in Patients with Crohn\u2019s Disease: A Prospective Placebo-Controlled Study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Pilot Study of Cannabidiol-Rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_82","unstructured":"Stero Biotechs Ltd (2022, July 12). A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-Sparing Therapy in Steroid-Dependent Crohn\u2019s Disease Patients, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT04056442."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jgh.13695","article-title":"Use of the Low-FODMAP Diet in Inflammatory Bowel Disease","volume":"32","author":"Gibson","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/ibd.21302","article-title":"Coping Skills for Reducing Pain and Somatic Symptoms in Adolescents with IBD","volume":"16","author":"McCormick","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/apt.12449","article-title":"Gut-Directed Hypnotherapy Significantly Augments Clinical Remission in Quiescent Ulcerative Colitis","volume":"38","author":"Keefer","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0005-7967(03)00146-3","article-title":"A Stress Management Programme for Crohn\u2019s Disease","volume":"42","year":"2004","journal-title":"Behav. Res. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/gutjnl-2016-313425","article-title":"Dietary and Pharmacological Treatment of Abdominal Pain in IBS","volume":"66","author":"Camilleri","year":"2017","journal-title":"Gut"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2036.2009.04018.x","article-title":"Comparison of the Prevalence of Fructose and Lactose Malabsorption across Chronic Intestinal Disorders","volume":"30","author":"Barrett","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/ecco-jcc\/jjx073","article-title":"Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled, Cross-over, Re-Challenge Trial","volume":"11","author":"Cox","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaac.2014.04.014","article-title":"Randomized Efficacy Trial of Two Psychotherapies for Depression in Youth with Inflammatory Bowel Disease","volume":"53","author":"Szigethy","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1097\/MIB.0000000000000568","article-title":"The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial","volume":"21","author":"Gerbarg","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12529-016-9580-9","article-title":"Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial","volume":"24","author":"Bampton","year":"2017","journal-title":"Int. J. Behav. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/156652408784533832","article-title":"The Role of Stress in the Development and Clinical Course of Inflammatory Bowel Disease: Epidemiological Evidence","volume":"8","author":"Maunder","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"ref_94","first-page":"e113027","article-title":"Efficacy of Acupuncture in the Treatment of Chronic Abdominal Pain","volume":"11","author":"Berger","year":"2021","journal-title":"Anesth. Pain Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MIB.0000000000000258","article-title":"Role of Transient Receptor Potential Channels in Intestinal Inflammation and Visceral Pain: Novel Targets in Inflammatory Bowel Diseases","volume":"21","author":"Wasilewski","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/nmo.12460","article-title":"The Endogenous Nociceptin\/Orphanin FQ-NOP Receptor System as a Potential Therapeutic Target for Intestinal Disorders","volume":"26","author":"Agostini","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Gavioli, E.C., and Rom\u00e3o, P.R.T. (2011). NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases. J. Amino Acids, 2011.","DOI":"10.4061\/2011\/836569"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/nmo.12390","article-title":"Activation of the Endogenous Nociceptin System by Selective Nociceptin Receptor Agonist SCH 221510 Produces Antitransit and Antinociceptive Effect: A Novel Strategy for Treatment of Diarrhea-Predominant IBS","volume":"26","author":"Fichna","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/jpet.113.209825","article-title":"Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases","volume":"348","author":"Sobczak","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1111\/j.1365-2982.2012.01999.x","article-title":"Transient Receptor Potential Vanilloid 4 Blockade Protects against Experimental Colitis in Mice: A New Strategy for Inflammatory Bowel Diseases Treatment?","volume":"24","author":"Fichna","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/j.pain.0000000000000386","article-title":"Reduction of Chronic Abdominal Pain in Patients with Inflammatory Bowel Disease through Transcranial Direct Current Stimulation: A Randomized Controlled Trial","volume":"157","author":"Volz","year":"2016","journal-title":"Pain"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"otab034","DOI":"10.1093\/crocol\/otab034","article-title":"Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes","volume":"3","author":"Honig","year":"2021","journal-title":"Crohn\u2019s Colitis 360"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/15\/4269\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:54:48Z","timestamp":1760140488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/15\/4269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":102,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["jcm11154269"],"URL":"https:\/\/doi.org\/10.3390\/jcm11154269","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}